When ere placebo-controlled trials no longer appropriate?

Controlled Clinical Trials

Volumn 18, Issue 6, 1997, Pages 602-612

  Brody, Baruch A ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Equipoise; Informed consent; Placebo control groups; Research ethics; Thrombolytic agents

Indexed keywords

FIBRINOLYTIC AGENT; PLACEBO; STREPTOKINASE;

CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ETHICS; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; INFORMED CONSENT; ARTICLE; MEDICAL ETHICS; METHODOLOGY; STANDARD;

CONTROLLED CLINICAL TRIALS; ETHICS, MEDICAL; FIBRINOLYTIC AGENTS; HUMANS; MYOCARDIAL INFARCTION; PLACEBOS; STREPTOKINASE;

EID: 0030665731     PISSN: 01972456     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-2456(97)00006-8     Document Type: Conference Paper

References (18)

1. Temple R. Government viewpoint of clinical trials. Drug Info J 1982;10-17.
2. Brody, BA. Ethical Issues in Drug Testing, Approval, and Pricing. New York: Oxford University Press; 1994.
3. AIMS Trial Study Group. Effect of intravenous APSAC on mortality reduction in acute myocardial infarction. Lancet March 12, 1988;545-549.
4. ASSET Study Group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Lancet Sept. 3, 1988;525-530.
5. GISSI, Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet Feb. 22, 1986;397-401.
6. ISIS Steering Committee. Intravenous streptokinase given within 0-4 hours of onset of myocardial infarction reduced mortality in ISIS-2. Lancet Feb. 28, 1987;502.
7. Andersen J et al. Multicenter reperfusion trial of intravenous anisoylated plasminogen streptokinase activator complex (APSAC) in acute myocardial infarction. J Am Coll Cardiol 1988;11:1153-1163.
8. Chalmers, TC. The ethics of randomization as a decision-making technique and the problem of informed consent. In: Abrams N and Buckner M, eds. Medical Ethics. Cambridge: MIT Press;1983:514-518.
9. Consensus Statement. Informed consent in emergency research. JAMA 1995;273: 1283-1287.
10. ISIS-II Protocol; Appendix B.
11. Fried C. Medical Experimentation. Amsterdam: North Holland; 1974.
12. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med 1987;317: 141-145.
13. Stipp D. A clot-dissolving drug is more effective in federal test of heart-attack patients. Wall Street Journal 11 February, 1986.
14. Pocock S. When to stop a clinical trial. Brit Med J 1992;305:235-239.
15. Meier P. Terminating a trial - the ethical problem. Clin Pharm and Ther 1979;25:637.
16. Levine R. Ethics and Regulation of Clinical Research. New Haven: Yale University Press; 1988:287-289.
17. Royal College of Physicians. Guidelines on the Practice of Ethics Committees in Medical Research Involving Human Subjects. London: Royal College; 1990:section 7.100.
18. FDA. Placebo-controlled and active-controlled drug study design. In: Clinical Investigator Information Sheets. Washington: FDA;1989.